Abbvie Inc.
AbbVie Inc. is a research-based, global pharmaceutical company that was founded in 2012 after the spinoff of Abbott Laboratories’ research-based businesses. The company is headquartered in North Chicago, Illinois and has approximately 30,000 employees worldwide with operations spanning over 170 countries. AbbVie focuses on developing treatments for some of the world’s most complex and serious diseases such as cancer, autoimmune diseases and cystic fibrosis through its four main therapeutic areas: Immunology; Oncology; Virology; and Neuroscience. AbbVie's portfolio of medicines includes Humira®, Viekira Pak®/Technivie®, Imbruvica® and Venclexta™ among others which have helped to improve the lives of many people around the world. In addition to their commitment to science-driven innovation, AbbVie also invests in charitable programs that foster community health initiatives across numerous countries including India, South Africa and China.
Headquarters
TREASURY, DEPT V310, BLDG AP34-3N 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL 600641802